MDXH
MDXH
NASDAQ · Biotechnology

Mdxhealth

$3.53
+0.13 (+3.82%)
As of Feb 8, 2:06 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 27.03M 27.35M 20.96M
Net Income 5.71M 6.20M 4.50M
EPS
Profit Margin 21.1% 22.7% 21.5%
Rev Growth +7.1% -0.5% +20.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 70.60M 71.52M 80.61M
Total Equity 66.74M 72.48M 68.20M
D/E Ratio 1.06 0.99 1.18
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 9.17M 9.44M 6.87M
Free Cash Flow 5.73M 4.10M 4.11M